U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 76

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr6:118972430
GRCh38:
Chr6:118651267
CEP85L, LOC129997071M1ILissencephalyPathogenic
(Nov 10, 2020)
criteria provided, single submitter
2.
GRCh37:
Chr12:49579343
GRCh38:
Chr12:49185560
TUBA1AL234P, L269PLissencephalyLikely pathogenic
(Feb 28, 2021)
no assertion criteria provided
3.
GRCh37:
Chr6:118953659
GRCh38:
Chr6:118632496
CEP85LS63R, S66RLissencephalyLikely pathogenic
(Mar 3, 2021)
criteria provided, single submitter
4.
GRCh37:
Chr6:118953614
GRCh38:
Chr6:118632451
CEP85LLissencephaly, Thick corpus callosumPathogenic
(May 12, 2021)
criteria provided, single submitter
5.
GRCh37:
Chr14:29237171-29237172
GRCh38:
Chr14:28767965-28767966
FOXG1I229KLissencephalyLikely pathogenic
(May 12, 2021)
criteria provided, single submitter
6.
GRCh37:
ChrX:61091-787353
Generalized hypotonia, Lissencephaly, Microcephaly,
Corpus callosum, agenesis of
Pathogenic
(Oct 1, 2020)
criteria provided, single submitter
7.
GRCh37:
Chr7:103183235-103183236
GRCh38:
Chr7:103542788-103542789
RELNF2205fsLissencephalyLikely pathogenicno assertion criteria provided
8.
GRCh37:
Chr7:103322603
GRCh38:
Chr7:103682156
RELNQ417*LissencephalyLikely pathogenicno assertion criteria provided
9.
GRCh37:
Chr17:40765942
GRCh38:
Chr17:42613924
TUBG1I257FLissencephalyLikely pathogenicno assertion criteria provided
10.
GRCh37:
Chr16:90002022
GRCh38:
Chr16:89935614
TUBB3M316T, M388TLissencephalyLikely pathogenicno assertion criteria provided
11.
GRCh37:
Chr6:3226888
GRCh38:
Chr6:3226654
TUBB2BS25GLissencephalyUncertain significanceno assertion criteria provided
12.
GRCh37:
Chr6:3226025
GRCh38:
Chr6:3225791
TUBB2BN100YLissencephalyLikely pathogenicno assertion criteria provided
13.
GRCh37:
Chr6:3225576
GRCh38:
Chr6:3225342
TUBB2BD249ELissencephalyUncertain significanceno assertion criteria provided
14.
GRCh37:
Chr7:103185769
GRCh38:
Chr7:103545322
RELNQ2109*LissencephalyLikely pathogenicno assertion criteria provided
15.
GRCh37:
Chr7:103243879
GRCh38:
Chr7:103603432
RELNI1069fsLissencephalyLikely pathogenicno assertion criteria provided
16.
PAFAH1B1LissencephalyLikely pathogenicno assertion criteria provided
17.
PAFAH1B1LissencephalyLikely pathogenicno assertion criteria provided
18.
PAFAH1B1LissencephalyLikely pathogenicno assertion criteria provided
19.
GRCh37:
Chr17:2583498-2583499
GRCh38:
Chr17:2680204-2680205
PAFAH1B1G349fsLissencephalyLikely pathogenicno assertion criteria provided
20.
GRCh37:
Chr17:2577425
GRCh38:
Chr17:2674131
PAFAH1B1L248PLissencephalyUncertain significanceno assertion criteria provided
21.
GRCh37:
Chr17:2577403
GRCh38:
Chr17:2674109
PAFAH1B1R241fsLissencephalyLikely pathogenicno assertion criteria provided
22.
GRCh37:
Chr17:2577358-2577359
GRCh38:
Chr17:2674064-2674065
PAFAH1B1V227fsLissencephalyLikely pathogenicno assertion criteria provided
23.
GRCh37:
Chr17:2576035
GRCh38:
Chr17:2672741
PAFAH1B1W219GLissencephalyUncertain significanceno assertion criteria provided
24.
GRCh37:
Chr17:2569344-2569345
GRCh38:
Chr17:2666050-2666051
PAFAH1B1E52fsLissencephalyLikely pathogenicno assertion criteria provided
25.
GRCh37:
Chr17:2541601
GRCh38:
Chr17:2638307
PAFAH1B1Q7*LissencephalyLikely pathogenicno assertion criteria provided
26.
GRCh37:
Chr14:102505442
GRCh38:
Chr14:102039105
DYNC1H1E3771KLissencephalyLikely pathogenicno assertion criteria provided
27.
GRCh37:
Chr14:102502959
GRCh38:
Chr14:102036622
DYNC1H1G3630SCharcot-Marie-Tooth disease axonal type 2OUncertain significance
(Feb 20, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr14:102499721
GRCh38:
Chr14:102033384
DYNC1H1R3438QLissencephalyUncertain significanceno assertion criteria provided
29.
GRCh37:
Chr14:102498755
GRCh38:
Chr14:102032418
DYNC1H1R3344Wnot providedPathogenic
(May 23, 2023)
criteria provided, single submitter
30.
GRCh37:
Chr14:102498679
GRCh38:
Chr14:102032342
DYNC1H1K3318NLissencephalyUncertain significanceno assertion criteria provided
31.
GRCh37:
Chr14:102483301-102483303
GRCh38:
Chr14:102016964-102016966
DYNC1H1L2605delLissencephalyLikely pathogenicno assertion criteria provided
32.
GRCh37:
Chr14:102461014
GRCh38:
Chr14:101994677
DYNC1H1W1054SLissencephalyUncertain significanceno assertion criteria provided
33.
GRCh37:
Chr14:102452883
GRCh38:
Chr14:101986546
DYNC1H1L774PLissencephalyLikely pathogenicno assertion criteria provided
34.
GRCh37:
Chr14:102452565
GRCh38:
Chr14:101986228
DYNC1H1V668DLissencephalyLikely pathogenicno assertion criteria provided
35.
GRCh37:
Chr14:102446841
GRCh38:
Chr14:101980504
DYNC1H1K305NLissencephalyLikely pathogenicno assertion criteria provided
36.
GRCh37:
ChrX:110653338
GRCh38:
ChrX:111410110
DCXL178V, L97VLissencephalyLikely pathogenicno assertion criteria provided
37.
GRCh37:
Chr17:79478481
GRCh38:
Chr17:81511455
ACTG1D179YLissencephalyUncertain significanceno assertion criteria provided
38.
GRCh37:
Chr14:102507012
GRCh38:
Chr14:102040675
DYNC1H1Charcot-Marie-Tooth disease axonal type 2OUncertain significance
(Aug 12, 2021)
criteria provided, single submitter
39.
GRCh37:
Chr1:197061157
GRCh38:
Chr1:197092027
ASPML1524fs, L3109fsMicrocephaly 5, primary, autosomal recessive, not provided, Microcephaly,
Lissencephaly
Pathogenic/Likely pathogenic
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr1:39916758
GRCh38:
Chr1:39451086
MACF1G4706R, G6765RLissencephaly, Lissencephaly 9 with complex brainstem malformationPathogenic/Likely pathogenic
(Feb 15, 2019)
no assertion criteria provided
41.
GRCh37:
Chr1:39929312
GRCh38:
Chr1:39463640
MACF1C5177F, C7236FLissencephalyPathogenic
(May 4, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr14:102469227
GRCh38:
Chr14:102002890
DYNC1H1R1603TIntellectual disability, autosomal dominant 13Uncertain significance
(Sep 1, 2017)
criteria provided, single submitter
43.
GRCh37:
Chr17:2339561-3447162
LissencephalyPathogenic
(Jan 1, 2017)
criteria provided, single submitter
44.
GRCh37:
Chr17:2339561-2826073
RAP1GAP2, CLUH, METTL16, PAFAH1B1Strabismus, Microcephaly, Lissencephaly,
Global developmental delay, Hypertonia, Nystagmus,
Absent speech
Pathogenic
(Jan 1, 2017)
criteria provided, single submitter
45.
GRCh37:
Chr17:1361431-2573023
Lissencephaly, Epileptic spasm, Abnormal facial shape
Pathogenic
(Jan 1, 2017)
criteria provided, single submitter
46.
GRCh37:
Chr6:118953666
GRCh38:
Chr6:118632503
CEP85LS64F, S61FLissencephaly, Lissencephaly 10Uncertain significance
(Jan 7, 2021)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr6:30691699
GRCh38:
Chr6:30723922
TUBBP287L, P307L, P215L, P243LComplex cortical dysplasia with other brain malformations 6, Multiple benign circumferential skin creases on limbs 1, not provided
Conflicting interpretations of pathogenicity
(Oct 12, 2022)
criteria provided, conflicting interpretations
48.
GRCh37:
Chr17:40765949
GRCh38:
Chr17:42613931
TUBG1S259Lnot specified, not providedConflicting interpretations of pathogenicity
(May 27, 2022)
criteria provided, conflicting interpretations
49.
GRCh37:
Chr6:3225452
GRCh38:
Chr6:3225218
TUBB2BQ291KComplex cortical dysplasia with other brain malformations 7Likely pathogenic
(Nov 19, 2015)
criteria provided, single submitter
50.
GRCh37:
Chr12:49578846-49578848
GRCh38:
Chr12:49185063-49185065
TUBA1AE434del, E399delInborn genetic diseases, not specifiedUncertain significance
(Apr 9, 2021)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr14:102469287
GRCh38:
Chr14:102002950
DYNC1H1R1623QIntellectual disability, autosomal dominant 13, Charcot-Marie-Tooth disease axonal type 2O, not provided
Pathogenic/Likely pathogenic
(Jun 9, 2022)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr14:102500319
GRCh38:
Chr14:102033982
DYNC1H1R3474WSpinal muscular atrophy with lower extremity predominance, not providedPathogenic
(Mar 25, 2022)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr14:102505162
GRCh38:
Chr14:102038825
DYNC1H1R3728PIntellectual disability, autosomal dominant 13Likely pathogenic
(Nov 18, 2014)
criteria provided, single submitter
54.
GRCh37:
Chr14:102452268
GRCh38:
Chr14:101985931
DYNC1H1R569PLissencephaly, Intellectual disability, autosomal dominant 13Pathogenic/Likely pathogenic
(May 19, 2015)
no assertion criteria provided
55.
GRCh37:
Chr14:102446852
GRCh38:
Chr14:101980515
DYNC1H1R309Hnot provided, Charcot-Marie-Tooth disease axonal type 2OPathogenic/Likely pathogenic
(Jul 27, 2022)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr12:49578923
GRCh38:
Chr12:49185140
TUBA1AV409A, V374ATubulinopathy, not provided, Lissencephaly due to TUBA1A mutation
Pathogenic/Likely pathogenic
(Mar 18, 2022)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr7:103143456-103143459
GRCh38:
Chr7:103503009-103503012
RELN, SLC26A5-AS1not providedUncertain significance
(Feb 13, 2015)
criteria provided, single submitter
58.
GRCh37:
Chr7:103205735
GRCh38:
Chr7:103565288
RELNL1734VInborn genetic diseases, Norman-Roberts syndrome, Familial temporal lobe epilepsy 7,
not specified, not provided
Conflicting interpretations of pathogenicity
(Oct 8, 2022)
criteria provided, conflicting interpretations
59.
GRCh37:
Chr2:130951772
GRCh38:
Chr2:130194199
TUBA3E, MZT2BR215CPrimary microcephaly, Seizure, Lissencephaly,
Global developmental delay
Likely pathogenic
(Dec 1, 2014)
no assertion criteria provided
60.
GRCh37:
Chr12:49579154
GRCh38:
Chr12:49185371
TUBA1AI332T, I297TTubulinopathy, Lissencephaly due to TUBA1A mutationLikely pathogenic
(Jul 1, 2018)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr12:49578945
GRCh38:
Chr12:49185162
TUBA1AR402C, R367CTubulinopathy, not provided, Autosomal recessive limb-girdle muscular dystrophy type 2D,
Lissencephaly due to TUBA1A mutation
Pathogenic/Likely pathogenic
(Apr 21, 2023)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr17:2583566
GRCh38:
Chr17:2680272
PAFAH1B1R371*Lissencephaly due to LIS1 mutation, Neurodevelopmental delayPathogenic
(Feb 8, 2013)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
ChrX:110574171
GRCh38:
ChrX:111330943
DCXR303*, R384*not provided, Lissencephaly type 1 due to doublecortin gene mutation, Ectopic tissue
Pathogenic
(Jun 22, 2022)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
ChrX:110653394
GRCh38:
ChrX:111410166
DCXR78L, R159Lnot provided, Lissencephaly type 1 due to doublecortin gene mutation, Ectopic tissue
Pathogenic
(Oct 2, 2021)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr6:3225062
GRCh38:
Chr6:3224828
TUBB2BE421KLissencephaly, Complex cortical dysplasia with other brain malformations 7Pathogenic/Likely pathogenic
(Dec 15, 2012)
no assertion criteria provided
66.
GRCh37:
Chr14:102498756
GRCh38:
Chr14:102032419
DYNC1H1R3344QCharcot-Marie-Tooth disease axonal type 2O, Intellectual disabilityPathogenic
(Oct 30, 2022)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr9:37784950
GRCh38:
Chr9:37784953
EXOSC3G31AMicrocephaly, Fetal akinesia deformation sequence 1, Severe intrauterine growth retardation,
Lissencephaly, Paucity of anterior horn motor neurons, Hypoplasia of the pons,
Abnormal cerebellum morphology, not provided, Pontocerebellar hypoplasia type 1B
Pathogenic/Likely pathogenic
(Aug 31, 2022)
criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr17:79478250
GRCh38:
Chr17:81511224
ACTG1R256WBaraitser-winter syndrome 2Pathogenic
(Dec 2, 2015)
criteria provided, single submitter
69.
GRCh37:
Chr17:79478256
GRCh38:
Chr17:81511230
ACTG1R254WAutosomal dominant nonsyndromic hearing loss 20, Baraitser-winter syndrome 2, not provided,
Baraitser-winter syndrome 2, Autosomal dominant nonsyndromic hearing loss 20
Pathogenic/Likely pathogenic
(Nov 12, 2022)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr17:2575939
GRCh38:
Chr17:2672645
PAFAH1B1Inborn genetic diseases, not provided, Lissencephaly due to LIS1 mutation
Pathogenic/Likely pathogenic
(Jun 7, 2023)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr17:2541604
GRCh38:
Chr17:2638310
PAFAH1B1R8*not provided, Lissencephaly due to LIS1 mutation, Intellectual disability
Conflicting interpretations of pathogenicity
(Dec 2, 2021)
criteria provided, conflicting interpretations
72.
GRCh37:
Chr12:49578884
GRCh38:
Chr12:49185101
TUBA1AR422H, R387HTubulinopathy, not provided, Lissencephaly due to TUBA1A mutation
Pathogenic
(Jun 3, 2022)
criteria provided, multiple submitters, no conflicts
73.
GRCh37:
Chr12:49578944
GRCh38:
Chr12:49185161
TUBA1AR402H, R367HTubulinopathy-associated dysgyria, Tubulinopathy, not provided,
Lissencephaly due to TUBA1A mutation
Pathogenic
(Dec 2, 2021)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr12:49579359
GRCh38:
Chr12:49185576
TUBA1AR264C, R229CTubulinopathy, Inborn genetic diseases, not provided,
Lissencephaly due to TUBA1A mutation
Pathogenic
(Oct 4, 2022)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr8:90983442-90983446
GRCh38:
Chr8:89971214-89971218
NBNK137fs, K219fsNBN-related condition, Hereditary cancer-predisposing syndrome, not provided,
BAP1-related tumor predisposition syndrome, Breast-ovarian cancer, familial, susceptibility to, 1, Microcephaly, normal intelligence and immunodeficiency,
Microcephaly, Lissencephaly
Conflicting interpretations of pathogenicity
(Aug 1, 2023)
criteria provided, conflicting interpretations
76.
GRCh37:
Chr13:25463509-25463512
GRCh38:
Chr13:24889371-24889374
CENPJS1081fsnot provided, Microcephaly, Lissencephaly
Pathogenic/Likely pathogenic
(May 12, 2021)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination